Brett Hurst

Publications | Journal Articles

Academic Journal

• Gibson, S.A, Liu, Y., Li, R., Hurst, B., Fan, Z., Siddharthan, V., Larson, D.P, Sheesley, A.Y, Stewart, R., Kunzler, M., Polejaeva, I., Van Wettere, A., Moisyadi, S., Morrey, J.D, Tarbet, B., Wang, Z., (2024). Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines. Viruses, 16:10, doi: 10.3390/v16101625
• Honda-Okubo, Y., Sakala, I.G, Andre, F., Tarbet, B., Hurst, B., Petrovsky, N., (2023). An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice. Vaccine, 5592-5602. doi: 10.1016/j.vaccine.2023.07.061
• Lane, T.R, Fu, J., Sherry, B., Tarbet, B., Hurst, B., Riabova, O., Kazakova, E., Egorova, A., Clarke, P., Leser, J.S, Frost, J., Rudy, M., Tyler, K.L, Klose, T., Volobueva, A.S, Velyaevskaya, S.V, Zarubaev, V.V, Kuhn, R.J, Makarov, V., Ekins, S., (2023). Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5. Antiviral Research, doi: 10.1016/j.antiviral.2023.105654
• Spengler, J.R, Carter, K., Delang, L., Durantel, D., Gowen, B., Herrero, L.J, Hurst, B., Janeba, Z., Jordan, R., Luo, D., Meier, C., Moffat, J., Rocha-Pereira, J., Seley-Radtke, K.L, Welch, S.R, Schang, L.M, (2023). Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023. Antiviral Research, 217, 105678. doi: https://doi.org/10.1016/j.antiviral.2023.105678
• Peterson, C.J, Hurst, B., Evans, W., Van Wettere, A., Gibson, S.A, Smee, D.F, Tarbet, B., (2023). Human IVIG treatment in a neurological disease model for Enterovirus A71 infection in 28-day-old AG129 mice. Virology580, 62-72. doi: 10.1016/j.virol.2023.02.002
• Owen, D.R, Allerton, C.M, Anderson, A.S, Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R.D, Carlo, A., Coffman, K.J, Dantonio, A., Di, L., Eng, H., Ferre, R., Gajiwala, K.S, Gibson, S.A, Greasley, S.E, Hurst, B.L, Kadar, E.P, Kalgutkar, A.S, Lee, J.C, Lee, J., Liu, W., Mason, S.W, Noell, S., Novak, J.J, Obach, R.S, Ogilvie, K., Patel, N.C, Petterson, M., Rai, D.K, Reese, M.R, Sammons, M.F, Sathish, J.G, Singh, R.S, Steppan, C.M, Stewart, A.E, Tuttle, J.B, Updyke, L., Verhoest, P.R, Wei, L., Yang, Q., Zhu, Y., (2021). An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science, 374:6575, 1586-1593. doi: 10.1126/science.abl4784

An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.

Publications | Other

An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.